Goldman Sachs Removes Abbott and Eli Lilly from “Conviction” Lists (ABT, LLY)
December 1st, 2009

Pharma giants Abbott Laboratories (ABT) and Eli Lilly & Co. (LLY) saw their ratings adjusted on Tuesday by analysts at Goldman Sachs.
Dividend.com archives (articles more than 30 days old) are only available to Dividend.com Premium subscribers.
Sign up for a Dividend.com Premium account for instant access to article archives, stock ratings on over 2,000 dividend-paying stocks, and much more! FREE TRIAL available!



Stock Screener
RSS
Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the